Literature DB >> 29120133

Midostaurin in FLT3-Mutated Acute Myeloid Leukemia.

Ranjit K Sahoo1,2, Lalit Kumar1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29120133     DOI： 10.1056/NEJMc1711340

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  2 in total

1.  LT-171-861, a novel FLT3 inhibitor, shows excellent preclinical efficacy for the treatment of FLT3 mutant acute myeloid leukemia.

Authors:  Zhou Yu; Jiaying Du; Hui Hui; Shaoxin Kan; Tongxin Huo; Kai Zhao; Tao Wu; Qinglong Guo; Na Lu
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.600

Review 2.  Cytogenetics of Pediatric Acute Myeloid Leukemia: A Review of the Current Knowledge.

Authors:  Julie Quessada; Wendy Cuccuini; Paul Saultier; Marie Loosveld; Christine J Harrison; Marina Lafage-Pochitaloff
Journal:  Genes (Basel)       Date:  2021-06-17       Impact factor: 4.141
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.